Biofield Therapy in Oncology: Modulation of Tumor Biology in Pancreatic and Liver Cancer
Objective
- Confirmatory research and advancement of prior biofield therapy research in cancers with the highest rate of mortality, examining the relevant biological mechanisms of action through multidimensional monitoring, rigorous treatment/sham/control conditions, dosage modulation, blockage of biofield signal, and exploratory distance therapy
Hypothesis
- Cancer cell mortality increases and proliferation decreases with biofield therapy relative to control and sham groups invitro and invivo in a way that is detectable not only through tumor remission/reduction but also by various biological markers
Projected Outcomes (In Process)
- Biofield therapy mice have higher survival rates
- Electromagnetic blocking of treatment does not prevent therapeutic effect
- Animal behavior shifts during treatment
- Change in neural correlates in therapists and mice during and after treatment
- Alteration of cancer-related epigenetic markers
- Alteration of cell signaling pathway proteins
- Altered microbiome diversity/abundance
- Immune modification, cytokines/immune cell profile
- Stem cell marker alteration
- Dosage effect is shown in audio treatment invitro
- Distance treatment invitro is effective